Navigation Links
PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022
Date:11/21/2013

London (PRWEB) November 21, 2013

PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022

Summary

GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - France Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.

France has established specialized AD facilities that have made diagnosis much easier in the rural areas of the country. Moreover, accessibility to affordable medications in France is among the highest of the EU countries. However, there is an widespread notion among family physicians in the EU that referral of an AD patient to specialists is sometimes not in the best interest of their patient, which prevents patients from proceeding along the usual pathway to the most effective management.

Scope

-Overview of Alzheimer’s Disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
-Detailed information on the key drugs in France including product description, safety and efficacy profiles as well as a SWOT analysis.
-Sales forecast for the top drugs in France from 2012-2022.
-Analysis of the impact of key events as well the drivers and restraints affecting France Alzheimer’s Disease market.

Reasons to buy

-Understand and capitalize by identifying products that are most likely to ensure a robust return
-Stay ahead of the competition by understanding the changing competitive landscape for Alzheimer’s Disease
-Effectively plan your M&A and partn
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Dry Eye Syndrome - Current and Future Players
2. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
10. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
11. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... The ... on the use of health IT to create efficiencies in healthcare information exchange, ... 2015 . Taking place at the Hyatt Regency Reston in Reston, Va. from ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like ... director of GreenFields of Geneva. During his first days on the job, he’s run ... nice seeing them, and I like knowing that they’re living in such a wonderful ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Brooks Group, a global ... a department devoted to helping organizations identify and keep the best talent both ... The Brooks Group believes in offering a solution that goes beyond simply providing ...
(Date:8/31/2015)... ... August 31, 2015 , ... PartnerTech ... Business Owners and provided a tour of their North American facility following the ... to international companies expanding business in the U.S. , The PartnerTech Inc. ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... According to ... Cancer Solution: Taking Charge of Your Life with Cancer is an excellent resource ... Santangeloon found The Cancer Solution to be helpful in explaining what cancer is in ...
Breaking Medicine News(10 mins):Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:PartnerTech Supports Economic Growth as Host 2Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2
... education bill in the state that allows private professional colleges ... ,Lok Sabha member Panniyan Ravindran, while talking to the Gulf ... said he would fight it. ,He was in ... anniversary of Kerala's former chief minister P.K. Vasudevan Nair. ...
... Bhopal and two of its doctors have been asked by ... for alleged// post-operative negligence resulting in the death of a ... Ayushman Hospital following swelling in her uterus and respiratory trouble. ... Since the tumor was not malignant and the possibility of ...
... Health Organization has communicated to countries the benefits of building ... 100 companies have sent in their request// to Roche AG, ... to combat a potential bird-flu pandemic. ,Though ... flu, yet they have enabled companies a list of things ...
... Health Canada has warned about the inherent risks involved ... ,The human milk is capable of ... There are chances that the human milk carries remnants ... consumed. Even unhygienic storage of milk, and not adhering ...
... care workers in the United States has risen, so ... ,According to Vanderbilt infectious disease experts Timothy ... should be provided to health care workers with latent ... test, particularly if they meet certain high-risk criteria. ...
... Pharma company Venus Remedies Ltd today said it ... its latest antibiotic fixed dose combination used in ... ,The new antibiotic combination, active against multi-resistant strains ... provides a broad-spectrum coverage of bactericidal activity, it ...
Cached Medicine News:
(Date:8/28/2015)... HILL, N.C. , Aug. 28, 2015 /PRNewswire/ ... market research projects can slow down the decision-making ... It is, therefore, absolutely critical for biopharmaceutical companies ... market research approval process for quicker and more ... research by Best Practices, LLC, nearly three-quarters of ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Originally discovered by ... Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory drug, ... Senju Pharmaceutical Co., Ltd under the trade name ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Tobramycin is a traditional antibiotic whose eye ... for the treatment of potential infection or inflammation caused ... China are able to produce tobramycin, ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... UPI ) announced today that it will release financial ... at the market close on Monday, November 2, 2009. ... results on Monday, November 2, 2009 at 3:30 p.m. Central ... Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will ...
... 21 Shire plc,(LSE: SHP, NASDAQ: SHPGY ), ... Biologics License Application (BLA) with the U.S.,Food and Drug ... for Fabry disease, by the end of the year. ... filed at the,request of FDA, has been approved, and ...
Cached Medicine Technology:Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
VACUETTE® Tube Holders should be used exclusively with VACUETTE® Blood Collection Needles as both components are designed for optimal compatibility with one another....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Less traumatic jaws offer a firm grasp while a self-retaining spring maintains hold on the needle. Use for grasping, applying endoloops, and driving needles during extracorporeal suturing....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Medicine Products: